Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro
María I. Zapata-Cardona, Lizdany Flórez‐Álvarez, Wildeman Zapata, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 16

Showing 16 citing articles:

Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
Damariz Marín-Palma, Jorge H. Tabares-Guevara, María I. Zapata-Cardona, et al.
Molecules (2021) Vol. 26, Iss. 22, pp. 6900-6900
Open Access | Times Cited: 85
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
Paula Andrea Cuartas Velásquez, Juan C. Hernández, Elkin Galeano, et al.
Clinical Pharmacology Advances and Applications (2024) Vol. Volume 16, pp. 1-25
Open Access | Times Cited: 10
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
Luis Adrián De Jesús‐González, Rosa M. del Ángel, Selvin Noé Palacios-Rápalo, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 383-383
Open Access | Times Cited: 5
Acute Coronary Syndrome in the COVID-19 Era—Differences and Dilemmas Compared to the Pre-COVID-19 Era
Ratko Lasica, Lazar Djukanovic, Igor Mrdović, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3024-3024
Open Access | Times Cited: 18
PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication in vitro
Damariz Marín-Palma, Jorge H. Tabares-Guevara, María I. Zapata-Cardona, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
María I. Zapata-Cardona, Lizdany Flórez‐Álvarez, Ariadna L. Guerra-Sandoval, et al.
AIMS Microbiology (2023) Vol. 9, Iss. 1, pp. 20-40
Open Access | Times Cited: 9
Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et)
Claudia Urueña, Ricardo Ballesteros-Ramírez, Alejandra Gomez‐Cadena, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Lipid compartments and lipid metabolism as therapeutic targets against coronavirus
Daniella Cesar-Silva, Filipe S. Pereira‐Dutra, Ana L.M. Giannini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks
Donatella Fiore, Maria Proto, Silvia Franceschelli, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2123-2123
Open Access | Times Cited: 8
Mapping the Lipid Signatures in COVID-19 Infection: Diagnostic and Therapeutic Solutions
Aishi Dasgupta, Shon Gangai, Rishikesh Narayan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14411-14433
Closed Access | Times Cited: 3
Effects of Statin Combinations on Zika Virus Infection in Vero Cells
Erica Españo, Jeong-Ki Kim
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 50-50
Open Access | Times Cited: 5
SARS-CoV-2 Phylointeractomics Reveal Functional Evolution of Its Variants Across Susceptible Human Organs
Xu Li, Peihan Wu, Danqi Bao, et al.
Research Square (Research Square) (2024)
Open Access
Drug Repositioning as an Antiviral Strategy Against Emerging Viruses
Selvin Noé Palacios-Rápalo, Carlos Daniel Cordero‐Rivera, Luis Adrián De Jesús‐González, et al.
˜The œLatin American studies book series (2024), pp. 273-317
Closed Access
Klotho Deficiency in Severe COVID-19: A Unifying Hypothesis
Natalia Campos‐Obando, M. Carola Zillikens, Román F. Macaya
COVID (2024) Vol. 4, Iss. 12, pp. 1833-1850
Open Access
In vitro antiviral effect of silver nanoparticles against SARS-CoV-2
Lizdany Flórez‐Álvarez, Juan C. Hernández, Wildeman Zapata, et al.
IATREIA (2022)
Open Access | Times Cited: 2
Page 1

Scroll to top